Register – 7th Saudi Lymphoma/Myeloma and 10th Hematopathology Overview

7th Saudi Lymphoma/Myeloma and 10th Hematopathology Overview

Oct 9–10, 2026 8:00 AM – 6:30 PM (KSA) Dhahran, Saudi Arabia Novotel Dhahran Hotel & Residences 16 CME Hours

Conference starts in

—

Days

—

Hours

—

Mins

—

Secs

43+

Speakers

700+

Delegates

CME Hours

7th SAUDI LYMPHOMA/MYELOMA AND 10th HEMATOPATOLOGY OVERVIEW

OBJECTIVES

The objectives of this conference are as follows

To provide updated information on the multidisciplinary diagnostic and therapeutic options for lymphoproliferative disorders.
To facilitate increased communication, collaboration, and exchange of knowledge and experience among hematologists, oncologists, pathologists, scientists, and other healthcare providers in the region.
To promote education and awareness among hematopathologists regarding the diagnosis of various hematology disorders.
To enable hematopathologists to understand the classification and differentiation of various diagnostics.
To learn the utilization of various histopathological, flow cytometric, molecular, and other lab markers in the diagnosis of hematological disorders.
To update participants with the latest diagnostic tools in hematopathology.

WHO SHOULD ATTEND?

This educational program is intended for Hematologists, Hemato-Pathologists, Medical Oncologists, Radiation Oncologists, Nuclear Medicine Specialists, Fellows and Residents in Training, Lab Scientists, Lab Technicians and technologists, and other healthcare providers who are involved in and/or interested in hematological disorders and SCT. State-of-the-art lectures, evidence-based hematology sessions, and satellite symposia covering the latest technological developments will be the main features of the program.

Full program (PDF)

08:00 – 08:30

Registration

Break

08:30 – 08:35

Welcome Remarks and Program Overview

Mubarak Almansour

Highlight

08:35

Session One

Moderators: Abdullah Alsaleh / Solaf Kanfar / Wael Alanazi

Session

08:35 – 09:00

What are the frontline treatment strategies for Multiple Myeloma in 2026 for transplant-eligible and ineligible?

Khalil Farsi (OM)

Session

09:00 – 09:25

RRMM Current Landscape and Future Directions

Omar Abduljalil (KSA)

Session

09:25 – 09:50

CAR-T vs. Bispecific therapy for relapsed Multiple Myeloma, which one and when?

Majed Alahmadi (KSA)

Session

09:50 – 10:00

Discussion

Session

10:00 – 10:15

Coffee Break

Break

10:15 – 10:45

Role and sequencing of BCMA agents in RR Multiple Myeloma

GSK Satellite Symposium

Ayman Alhejazi (KSA)

Symposium

10:45 – 11:30

Roche Satellite Symposium

Reyad Dada / Ghazi Alotaibi / Manar Abdulbaqi

Introduction – Saud Asubait
Anchoring the standard of care in first-line DLBCL
Charting the changing currents in second-line treatments
Mapping the treatment journey in heavily pretreated patients

Symposium

11:30 – 13:30

Juma'ah Prayer and Lunch Break

Prayer at 12:00 PM

Break

13:30

Session Two

Moderators: Musa Alzahrani / Abdulkareem AlGarni / Aamer Bugnah

Session

13:30 – 14:00

Frontline mantle cell lymphoma: do we still need autologous transplant?

Toby Eyre (UK)

Session

14:00 – 14:30

Local Experience/Updates in DLBCL

Mohammed Aldarweesh (KSA)

Session

14:30 – 15:00

Follicular lymphoma: second-line therapy is being rewritten

Ann Lacasce (USA)

Session

15:00 – 15:15

Coffee Break

Break

15:15

Session Three

Moderators: Ayman Alhejazi / Ghazi Alotaibi / Omar Abduljalil

Session

15:15 – 15:45

Real-World Large-Cohort Report of Equecabtagene Autoleucel in R/R MM from FUMANBA-1

IASO Satellite Symposium

Prof. Lu Jin (CHN)

Symposium

15:45 – 16:15

Smoldering Multiple Myeloma

Maria Victoria Mateos (ES)

Session

16:15 – 16:45

Summary of new response criteria in Multiple Myeloma

Shaji Kumar (USA)

Session

16:45 – 17:05

CAR-T in KSA: Advancing the Future of Multiple Myeloma Care

Johnson & Johnson Satellite Symposium · Moderator: Abdullah Alsaleh

Ayman Alhejazi (KSA)

Symposium

17:05 – 17:15

Coffee Break

Break

17:15

Session Four

Moderators: Ayman Ibrahim / Manar Abdulbaqi / Khalid Aldosari

Session

17:15 – 17:45

Early-stage Hodgkin Lymphoma: How immunotherapy is changing the treatment landscape.

Stephen Ansell (USA)

Session

17:45 – 18:15

R/R CLL: best sequencing strategy

John Allan (USA)

Session

18:15 – 18:45

Best management strategy in R/R T-cell-rich B-cell lymphoma

Tycel Phillips (USA)

Session

18:45

Discussion – End of Day 1

Highlight

08:30 – 08:35

Welcome Remarks and Program Overview

Ahmed Al-Bahrani, MD

Highlight

08:35

Session One

Moderators: Dr. Mohammed Al Mohammadi and Dr. Sameera Alsafwani

Session

08:35 – 08:55

Expect the unexpected: intriguing cases in hematopathology

Reem Alrabeh, MD

Session

08:55 – 09:15

Flowcytometry in the diagnosis of hematological malignancies

Mariam Alghazal, MD

Session

09:15 – 09:35

Diagnostic classification of myeloid neoplasm: WHO 5th vs ICC 2022 for myeloid neoplasm

Maher Aljohani, MD

Session

09:35 – 09:45

Discussion

Session

09:45 – 10:00

Coffee Break

Break

10:00

Session Two

Moderators: Dr. Abdulmajeed Al Abdullateef and Dr. Fatimah Al Ghanim

Session

10:00 – 10:20

From screening tests to precision diagnosis of acquired and congenital coagulopathies

Rabab Al Dawood, MD

Session

10:20 – 10:40

Diagnostic strategies and challenges in platelet function testing

Rahaf Altahan, MD

Session

10:40 – 11:00

The Evolving landscape of factor XIII testing: method, pitfalls, and best practices

Mohammed AlSharif, MD

Session

11:00 – 11:20

Transfusion challenges in multiple myeloma

Ammar Alsughayir, MD

Session

11:20 – 11:30

Discussion

Session

11:30 – 13:00

Prayer and Lunch Break

Prayer at 12:00 PM

Break

13:00

Session Three

Moderators: Dr. Ahmed Al Bahrani and Dr. Haifa Almuhtaresh

Session

13:00 – 13:20

Distinguishing hairy cell leukemia from splenic marginal zone lymphoma: diagnostic pearls for the hematopathologist

Mona Alfaraj, MD

Session

13:20 – 13:40

New updates in AML, Measurable residual disease a consensus approach from ELN-MRD working group

Heba Raslan, MD

Session

13:40 – 14:00

MPD – Myelofibrosis

Ahmed Al Rajjal, MD

Session

14:00 – 14:10

Discussion

Session

14:10 – 14:25

Coffee Break

Break

14:25

Session Four

Moderators: Dr. Mukhtar Buhlaiga and Dr. Naif Bin Muhanaa

Session

14:25 – 14:45

The ultimate Transfusion puzzle: strategies for anti-Rh17 management.

Fatma Aldarweesh, MD

Session

14:45 – 15:05

Evolving Practice in Transplant & Cellular Therapies

Ahmed Al-Bahrani, MD

Session

15:05 – 15:25

Updates on mismatch-unrelated hematopoietic stem cell transplantation

Mohammad Awaji, PhD

Session

15:25 – 15:35

Discussion and Closing Remarks

Ammar Alsughayir, MD

Session

15:35

End of Day 2

Highlight

Speaker (Local) (12)

Reem Ala Alrabeh

Section Head- Hematology, Coagulation and Flowcytometry Lab at King Fahad Specialist Hospital - Dammam

Hematopathology

King Fahad Specialist Hospital - Dammam

Dammam, Saudi Arabia

Maher M. Aljohani, MD, MSc

Consultant and Assistant Professor of Hematopathology | Chairman of the Department of Pathology and Laboratory Medicine, Prince Mohammad Bin Abdul Aziz Hospital (PMBAH) of National Guard Health Affairs, Madinah, Saudi Arabia

Hematopathology

Prince Mohammad Bin Abdul Aziz Hospital (PMBAH)

Medina, Saudi Arabia

Rabab A. Al Dawood, MBBS

Hematopathology Consultant/Coagulation and Hemostasis, King Fahad Specialist Hospital, Dammam, Saudi Arabia

Hematopathology

King Fahad Specialist Hospital - Dammam

Dammam, Saudi Arabia

Rahaf Altahan

Consultant Hematopathologist at King Fahad Medical City and the Program Director of the King Saud University Board in Hematopathology and Transfusion Medicine

Hematopathology

King Fahad Medical City

Riyadh, Saudi Arabia

Mona M. Alfaraj, MD, KSUF

Consultant Hematopathologist & Blood Transfusionist at Qatif Health Network QHN

Hematopathology

Qatif Health Network QHN

Qatif, Saudi Arabia

Prof. Heba Nabil Ismail Raslan

Consultant Hematopathology, King Fahad Specialist Hospital – Dammam (KFSH-Dammam) and Professor of Hematopathology, National Cancer Institute, Cairo University

Hematopathology

King Fahad Specialist Hospital – Dammam (KFSH-Dammam)

Dammam, Saudi Arabia

Ahmed Alrajjal, MD

Associate Consultant Pathologist at Princess Noorah Oncology Center National Guard Hospital- Jeddah

Hematopathology

Princess Noorah Oncology Center National Guard Hospital- Jeddah

Jeddah, Saudi Arabia

Mohammad Awaji

Principal Director of the Histocompatibility & Immunogenetics Laboratory at King Fahad Specialist Hospital-Dammam

Pathology & Lab Medicine

King Fahad Specialist Hospital - Dammam

Dammam, Saudi Arabia

Mohammed Abdullah AlSharif

Hematopathology Consultant, Department of Pathology and Laboratory Medicine, King Abdullah Bin Abdulaziz University Hospital, Riyadh

Hematopathology

King Abdullah Bin Abdulaziz University Hospital, Riyadh

Riyadh, Saudi Arabia

Dr. Majed Alahmadi

Consultant, Adult Hematology/BMT

Hematology/Oncology

Princess Noorah Oncology Center, King Abdulaziz Medical City KAMC, Jeddah

Jeddah, Saudi Arabia

Mohammed Ibrahim M Aldarweesh, MD

Consultant Adult hematology, Lymphoma, Myeloma and Stem Cell Transplant

Hematology/Oncology

King Fahad Specialist Hospital - Dammam

Dammam, Saudi Arabia

Dr. MARIAM RADI ALGHAZAL

Medical Director in Dammam Regional Laboratory & Section Head of Hematopathology

Hematopathology

Dammam Regional Laboratory

Dammam, Saudi Arabia

Speaker (International) – Virtual (7)

Shaji Kunnathu Kumar, MD

Consultant - Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnes

Hematology

Mayo Clinic, Rochester, Minnesota

Rochester, United States

TOBY A. EYRE, MD

Haematology Consultant (Lymphoma and CLL), CLL Lead, Honorary Senior Clinical Lecturer in Haematolog

Hematology

Oxford University Hospitals, NHS Foundation Trust

Oxford, United Kingdom

Ann Steward LaCasce, MD, MMSc

Program Director, Dana Farber/MGB Heme/Onc Fellowship and Associate Professor of Medicine Lymphoma Program

Hematology

Dana-Farber Cancer Institute

Boston, United States

Maria-Victoria Mateos, MD, PhD

Consultant Physician in the Haematology Department and Associate Professor of Medicine at the University of Salamanca, Spain

Hematology

University of Salamanca, Spain

Salamanca, Spain

John Allan

Associate Professor of Clinical Medicine, Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, NYC

Hematology/Oncology

Weill Cornell Medical College

New York, United States

Stephen M Ansell, MD, PhD

Consultant - Division of Hematology, Department of Internal Medicine

Hematology/Oncology

Mayo Clinic, Rochester, Minnesota

Rochester, United States

Tycel J. Phillips, MD

Associate Professor of Medicine

Hematology/Oncology

City of Hope National Medical Center

Duarte, United States

Moderator (17)

Musa Fares Alzahrani, MD

Assistant Professor and Consultant Hematologist, King Saud University Hospital

Hematology/Oncology

King Saud University Hospital

Riyadh, Saudi Arabia

Ayman Alhejazi, MD

Assistant Professor of Hematology/Oncology King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA | Consultant, Div. of Adult Hematology and Stem Cell Transplantation Department of Oncology King Abdulaziz Medical City

Hematology

King Abdulaziz Medical City - Riyadh

Riyadh, Saudi Arabia

Ayman Mubarak Habiballa Ibrahim, FRCPath, MRCP, MSc Haematopathology, MBBS

Consultant Hematologist, King Abdulaziz Medical City - Riyadh

Hematology

King Abdulaziz Medical City - Riyadh

Riyadh, Saudi Arabia

Manar Mohammad Abdulbaqi, MD

Hematology Consultant at King Fahad Specialist Hospital - Dammam

Hematology

King Fahad Specialist Hospital - Dammam

Dammam, Saudi Arabia

Abdullah Sulaiman Alsaleh

Section Head, Division of Adult Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City - Riyadh

Hematology/Oncology

King Abdulaziz Medical City - Riyadh

Riyadh, Saudi Arabia

Mohammed Hassan Sulaiman Almohammadi

• Medical Director of Laboratory Services at Dr Sulaiman Alahbib Medical Group (HMG), Western Region, KSA

Hematopathology

Dr Sulaiman Alahbib Medical Group (HMG), Western Region, KSA

Jeddah, Saudi Arabia

Sameera Abdulkareem Alsafwani

Hematopathology Consultant and Blood Bank, QCH, MOH Director of Laboratory

Hematopathology

Qatif Health Network/ Qatif Central Hospital

Qatif, Saudi Arabia

Abdulmajeed Abdulaziz Alabdullateef, MD

Director of Transfusion Medicine & Cellular Therapy Fellowship program at King Saud University Riyadh

Hematopathology

King Saud University Riyadh

Riyadh, Saudi Arabia

Mukhtar Mohammedfayez Buhlaiga

Consultant Transfusion Medicine, Immunohematology and Blood Banking at Maternity and Children’s Hospital in Dammam

Hematopathology

Maternity and Children’s Hospital in Dammam

Dammam, Saudi Arabia

Solaf Sami A Kanfar, MD

Consultant, Adult Hematology and SCT and Chairperson Adult Hematology and SCT Department, King Fahad Specialist Hospital - Dammam

Hematology/Oncology

King Fahad Specialist Hospital - Dammam

Dammam, Saudi Arabia

Wael Abdullah Alanazi, MD

Consultant in Adult Hematology and Bone Marrow Transplantation at King Fahad Specialist Hospital-Dammam

Hematology/Oncology

King Fahad Specialist Hospital - Dammam

Dammam, Saudi Arabia

Abdulkareem AlGarni, MD

Consultant Hematologist at King Abdulaziz Hospital, MNGHA, and an Assistant Professor at King Saud bin Abdulaziz University for Health Sciences

Hematology/Oncology

King Abdulaziz Hospital, MNGHA

Al Ahsa, Saudi Arabia

Ghazi Saud Alotaibi, MD

Consultant Hematologist and Director of the King Saud University Oncology Center | Assistant Professor of Medicine

Hematology/Oncology

King Saud University Medical City

Riyadh, Saudi Arabia

Khalid Mohammed Aldosari, MD

Consultant Hematologist at King Abdulaziz Medical City, Ministry of National Guard Health Affairs in Riyadh

Hematology/Oncology

King Abdulaziz Medical City - Riyadh

Riyadh, Saudi Arabia

Dr. Aamer Bugnah

Consultant in Adult Hematology and Stem Cell Transplantation at King Saud Medical City, Riyadh

Hematology/Oncology

King Saud Medical City, Riyadh

Riyadh, Saudi Arabia

Dr. Fatimah Abdulwahid Al Ghanim

Head of Blood Bank, Qatif Central Hospital (QCH)

Hematopathology

Qatif Central Hospital (QCH)

Qatif, Saudi Arabia

Dr. Naif Bin Muhannaa

Acting Specialty Consultant in Transfusion Medicine at King Fahad Medical City, Riyadh

Hematopathology

King Fahad Medical City

Riyadh, Saudi Arabia

Chairman, Scientific Committee (1)

Prof. Mubarak Almansour

Chairman & Consultant, Adult Medical Oncology, Princess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs - Jeddah | Professor, College of Medicine - Jeddah, KSAU-HS

Oncology

Princess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs - Jeddah

Jeddah, Saudi Arabia

Speaker/Moderator (1)

Omar Zeid Abduljalil, MBBS, SF-AH, SB-Med, MHQS

Consultant in Adult Hematology and Bone Marrow Transplantation at King Fahad Specialist Hospital in Dammam

Hematology

King Fahad Specialist Hospital - Dammam

Dammam, Saudi Arabia

Chairman, Scientific Committee/Speaker/Moderator (1)

Ahmed Taher Al-Bahrani

Consultant, Pathology (Hematology), Transfusion Medicine and Stem Cell Processing, KFSHD | Head, Stem Cell Transplantation Laboratory, KFSHD | Head, Therapeutic Apheresis Unit, KFSHD

Hematopathology

King Fahad Specialist Hospital –Dammam

Dammam, Saudi Arabia

Co-Chair, Scientific Committee/Speaker (1)

Ammar Hasan Alsughayir, MBBS, KSUPATH, JBH, EMBA

Chairman, Transfusion Medicine Service Department Pathology, Pathology and Clinical Laboratory Medicine, King Fahad Medical City

Hematopathology

King Fahad Medical City

Riyadh, Saudi Arabia

Speakers (GCC) (1)

Dr. Khalil Farsi

Senior Consultant, Hematology & BMT

Hematology/Oncology

Sultan Qaboos University Hospital

Muscat, Oman

Speaker (Local) - Virtual (1)

Fatima Aldarweesh, MD, QIA

Associate Professor of Pathology

Hematopathology

The University of Chicago

Chicago, United States

Speaker - Satellite Symposium (Sponsored) (1)

Prof. Lu Jin

Chief Physician, Professor, and Doctoral Supervisor

Hematology/Oncology

Peking University People's Hospital / Peking University Institute of Hematology

Online Registration Has Closed

Online registration for 7th Saudi Lymphoma/Myeloma and 10th Hematopathology Overview is now closed — it closed on 6 October 2026.
You can still register in person at the venue on the day of the event — come to the registration desk when you arrive.

Contact:
+966 53 728 8448
ssbmt@mngha.med.sa
ssbmt1@gmail.com
events@ssbmt.org

← Return to Homepage

Terms and Conditions

Please read before you register

This event is held in person only. There is no online or virtual attendance.
Please type your first and last name exactly as you want them printed. Your certificate is produced from what you enter here.
Enter your Saudi Commission (SCFHS) registration number in this format — 12RM0001234 — with no spaces or dashes. CME hours cannot be credited to your profile without a correct number.
CME hours are earned by attendance. You must scan in when you arrive and scan out when you leave, on each of the 2 days of the event. Your recorded attendance is reviewed before certificates are issued, and partial attendance may not qualify for CME credit.
You confirm that everything you have entered is correct and truthful.
Attendance is limited to registered participants only. Children and accompanying guests cannot be admitted.

1. Registration Agreement

By registering for the 7th Saudi Lymphoma/Myeloma and 10th Hematopathology Overview, you agree to the following terms and conditions:

2. Information Accuracy

All information provided in this registration form must be accurate and truthful.
You are responsible for ensuring that your contact details (email and mobile) are correct.
Any false or misleading information may result in cancellation of registration.

3. Data Privacy & Protection

Your personal information will be used solely for conference-related purposes.
We will not share your data with third parties without your consent.
Data will be stored securely in compliance with applicable privacy laws.
You may request deletion of your data by contacting us at ssbmt@mngha.med.sa

4. Conference Participation

Registration confirmation will be sent to your registered email.
This is a free registration for the conference.
Attendance is subject to venue capacity and event guidelines.
You must present valid identification at the registration desk.

5. Code of Conduct

All attendees must maintain professional conduct throughout the event.
Respectful behavior towards speakers, organizers, and fellow attendees is mandatory.
The organizing committee reserves the right to remove any participant who violates the code of conduct.

6. Photography & Recording

The event may be photographed and recorded for promotional purposes.
By attending, you consent to the use of your image in conference materials.

7. Changes & Cancellations

The organizing committee reserves the right to modify the program or cancel the event due to unforeseen circumstances.
Participants will be notified of any significant changes via registered email.

8. Liability

SSBMT is not responsible for personal belongings, injuries, or damages during the event.
Participants attend at their own risk and are responsible for their travel and accommodation arrangements.

9. Contact Information

For any questions or concerns, please contact:

Email: ssbmt@mngha.med.sa
Email: ssbmt1@gmail.com
Email: events@ssbmt.org
Mobile: +966 53 728 8448
Website: ssbmt.org

By clicking "I Accept", you acknowledge that you have read, understood, and agree to these terms and conditions.

7th Saudi Lymphoma/Myeloma and 10th Hematopathology Overview

7th SAUDI LYMPHOMA/MYELOMA AND 10th HEMATOPATOLOGY OVERVIEW

Speakers & Faculty (43)

Online Registration Has Closed

Our Sponsors & Partners

Terms and Conditions

1. Registration Agreement

2. Information Accuracy

3. Data Privacy & Protection

4. Conference Participation

5. Code of Conduct

6. Photography & Recording

7. Changes & Cancellations

8. Liability

9. Contact Information